Brief: Heat Biologics Announces New PTX-35 Preclinical Data In Organ Transplantation And Provides Update On HS-110

Scorpius Holdings

12/01/2022 13:24

Jan 12 (Reuters) - Heat Biologics Inc  HTBX.O :
    * HEAT BIOLOGICS ANNOUNCES NEW PTX-35 PRECLINICAL DATA IN
ORGAN
TRANSPLANTATION AND PROVIDES UPDATE ON HS-110
    * HEAT BIOLOGICS INC - A SINGLE DOSE OF PRECLINICAL VERSION
OF
PTX-35 (MPTX-35), WAS ABLE TO EXPAND REGULATORY T CELLS
    * HEAT BIOLOGICS INC - LONG-TERM SURVIVING GRAFTS SHOWED A
MARKED
INCREASE IN TREG INFILTRATION WHICH DIRECTLY CORRELATED WITH
MPTX-35 AGONIST ACTIVITY

Source text for Eikon:  ID:nGNX1dNBXM 
Further company coverage:  HTBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))